Clinical trial
Study of Expectorant Activity of Oral N-acetylcystein (NAC) in Patients With…
NCT00205647 · Wake Forest University, Other · Completed
Key facts
| NCT number | NCT00205647 |
|---|---|
| Title | Study of Expectorant Activity of Oral N-acetylcystein (NAC) in Patients With Stable Chronic Bronchitis |
| Official title | A Phase II Multicenter Efficacy, Safety and Dose-Effect Study of the Expectorant Activity of Oral N-acetylcystein (NAC) in Patients With Stable, Chronic Bronchitis |
| Lead sponsor | Wake Forest University, Other |
| Collaborators | Zambon SpA Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Bronchitis |
| Intervention type | Drug |
| Interventions | Oral N-acetycystein (NAC) |
| Enrollment | 240 |
| Start date | Jan 1, 1997 |
| Completion | Mar 1, 2000 |
| First posted | Sep 20, 2005 |
| Last update posted | Nov 6, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: